FOLH1 and posterior cortical atrophy: Positron emission tomography/computed tomography (PET/CT) with [68Ga]-labeled prostate-specific membrane antigen inhibitors ([68Ga]Ga-PSMA) has been widely used in the clinical staging of primary PCa and the restaging of biochemically recurrent PCa [20, 21].